Your Genes Can Open a World of Possibilities
Uniting powerful next generation sequencing technology with our assays and analytics to inform your physician and facilitate the development of a customized treatment plan as unique as you are.
Physicians use precision medicine to personalize healthcare treatment based on variations in your genes and how these variations may affect your current and future health. Customized treatment and screening plans may translate into shorter hospital stays, fewer medication trials, earlier detection or certain cancers and the ability to feel better sooner.
Anita underwent hereditary cancer screening after her colon cancer diagnosis at the age of 52. Testing revealed a mutation in her MLH1 gene, and Anita and her two siblings were subsequently diagnosed with Lynch syndrome. Anita's asymptomatic son also tested positive for Lynch syndrome, prompting his physicians to develop a care plan that proactively prevents and detects cancers associated with the syndrome.
Charles was diagnosed with bipolar I disorder at the age of 20, and he responded poorly to his therapeutic medications over the next 13 years. He underwent pharmacogenetics testing and discovered he was a poor metabolizer of several of his prescribed medications. Charles' clinicians altered his medication regimen based on his results, and within five months, his bipolar symptoms were relieved and medication side effects were eliminated.
Pharmacogenetics is the study of how a person’s genetic makeup affects how their body processes medications in some drug classes. Our InspexionTM Pharmacogentic Test targets specific regions in key pharmacogenes. This service can help your physician determine what medications are best suited for you.
Approximately 5-10% of cancers are hereditary in nature, meaning they are due to specific genetic variations passed from parent to child. The Kailos Genetics ExpedioTM Hereditary Cancer Test sequences regions in genes with elevated cancer risks. If our test shows that you have one of these variations, your physician may choose to modify your cancer screening regimen.Â For example, if you have a specific mutation in your BRCA1 gene, your physician may decide for you to start having mammograms earlier than what is recommended for most people.
Your physician will receive your results approximately 2 days before you do, providing an opportunity to go over them ahead of time. If a variation is found, your physician will discuss your options with you. In the case of our ExpedioTM Hereditary Cancer Test, you may also be contacted by or referred to a certified genetic counselor to discuss what your variation may mean for your health.
Yes, since the screening we do is genetic, one of your parents will most likely have the same variation that you have. Any child of that parent has a 50% chance of inheriting that variation as well. Additionally you have a 50% chance of passing on the variation to each of your biological children.